chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body ache, fever, and headache started on the 1st WO weeks  after vaccination.
Wife called and reported patient became short of breath Saturday 11/07/2009 after receiving H1N1 vaccine on Thursday 11/05/2009. Wife states "husband was cleaning gutter Saturday am when he became very short of breath".
Fever; Chills; Joint pain; Muscle aches; tiredness; This is a spontaneous report from a contactable nurse. A 21-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0193) via an unspecified route of administration in the left arm on an unknown date (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The patient was allergic to penicillin. It was unknown whether the patient was pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on an 20Apr2021 at 16:30 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 00:00, the patient experienced fever, chills, joint pain, muscle aches and tiredness with the second dose. The patient reported to have experienced no symptoms with the first dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events ever, chills, joint pain, muscle aches and tiredness were not recovered.  No follow-up attempts are needed. No further information is expected.
He got the Pfizer Covid 19 Vaccine and afterwards now his heart rate has been high; I did check it here today and seems little higher than normal first one I roam around and it goes even higher; This is a spontaneous report from a Pfizer sponsored program. This is a spontaneous report from a contactable 57-year-old male consumer (patient) .A 57-year-old male received bnt162b2 (Pfizer-biontech covid-19 vaccine, Solution for injection, Batch/lot number: unknown) via an unspecified route of administration on 17Sep2021 as DOSE 2, SINGLE for covid-19 immunization.The patient medical history had included blood clots and  received blood thinner for blood clots. The patient concomitant had included vitamin B-complex and vitamin D. It was reported that patient did not receive any vaccination prior to the vaccination. The patient previously took bnt162b2 (Pfizer-biontech covid-19 vaccine, Solution for injection, Batch/lot number:FC3180 ) via an unspecified route of administration on 27Aug2021 as DOSE 1, SINGLE for covid-19 immunization.On Sep 2021 the patient had experienced that after getting Pfizer Covid 19 Vaccine and afterwards now his heart rate has been high and reported that check it here today and seems little higher than normal first one I roam around and it goes even higher. The clinical outcome of the events were unknown.  The lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow up.
Chills, aches, joint pain, tender lump in left axilla, injection site pain, fatigue
*12/21-22-increased soreness at site of injection...resolved Onset on 12/28 of Swollen lymph nodes, with pain, on Right side of body with increased sensitivity at Left Axillary/side of breast area. Onset on 12/30 Fever, Severe Body aches/joint pain, dry cough, chest pain with min SOB, Headache. *Exposure to 4 people on Sat 12/26 who have tested positive for Covid on 1/1/20 but their symptoms began 12/28 through 01/30.
After pt. received the vaccine she remained seated outside of her room for the recommended 15 minutes, after her time was up she stood up to walk back into her room and fell. Pt. did not think she lost consciousness. She was immediately attended to by facility staff. She BP was unstable (high then low). She was seated back in her chair and seemed alert and oriented.
Lightheaded/ Dizziness, upper body perspiring  Lasted 5-10 minutes
1 month after: got sick with colds weekly 2 months after: sick + insomnia 3 months (Nov): sinusitis, sick, insomnia, shakes, night sweats Jan: Sinus surgery April: still sick, docs cant figure it out April: Find Lab enter into clinical study. Am diagnosed with adverse covid vaccine reaction. Was put on maraviroc and pravastatin August. Slowly improving, but I have 5.5% of spike proteins in my system
Pt recvd a series of 3 Engerix-B on 18OCT90, 19NOV90 & 25APR91 & was a non-responder;
pt recv vax 15JAN96 & just a few days later pt broke out w/true varicella;MD felt that this was surely secondary to a prev exposure vs vaccine induced;pt sibling was also reported (WAES96031763);
fever > 102 F 4 - 5 days, fever > 101 F 7-9 days; extreme body/muscle/joint ache; unable to walk 1 day; severe headache lasting 11-12 days; caused patients first shingles outbreak
Rash  with itching to both arms and on right thigh.  Slight tingling on face/lower lip.  injection of methylprednisolone sod. in office.   Rx for prednisone 20 mg twice a day oral for 5 days.  Pepcid 20mg twice daily and Benadryl 25mg at bedtime for next 3-5 days or until Rash improves.
Large local reaction with erythema 5-6 inches long 4-5 inches wide with central firm area 2.5x2.5 inches very tender.
This spontaneous report was received from a 69 year old female consumer reporting on herself, a patient with thyroid cancer, breast cancer, carcinoma of the right ear and DEMEROL allergy. On 13-JUL-2013 the patient received a shot of ZOSTAVAX (dose, route and lot number were not provided) injection in the right arm for doctor recommendation. Concomitant medications were not provided. Consumer reported that on 18-JUL-2013, she developed a red, "leathery" welt on the right arm, 4 inches above the wrist after receiving ZOSTAVAX. Patient received CORTIZONE cream as treatment for the adverse event. Routine blood work was performed (results not provided). Patient did not seek medical attention. The outcome of red, "leathery" welt on the right arm was reported as not recovered/not resolved. The relationship between ZOSTAVAX and the events was not reported. Additional information has been requested.
Patient developed chest pain 5 minutes after vaccine administration. Patient was transferred to the EC and was given ASA, EKG (WNL), chest x-ray (negative) IV fluids and then DC home.
Salty taste in mouth; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 71 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 15Feb2021 15:45 (Lot number: EN6201) at the age of 71 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "mild hypertension" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; CHANCA PIEDRA. Vaccination history included: Covid-19 (product=COVID 19, brand=Pfizer,, lot number=EL9263,, lot unknown=False,, administration date=25Jan2021, administration time=03:00 AM, dose number=1,, vaccine location=Left arm}]), for COVID-19 immunisation. The following information was reported: DYSGEUSIA (non-serious) with onset 22Feb2021 08:30, outcome "recovering", described as "Salty taste in mouth". Therapeutic measures were not taken as a result of dysgeusia.  No follow-up attempts are possible. No further information is expected.
Received FLUMIST Nasal on 12/30/11 - was seen in office 1/3/12 and parents stated that patient started with congestion, cough & fever.
extremely tired; Arm pain (injection arm); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm pain (injection arm)) and FATIGUE (extremely tired) in a 7-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 1 dosage form. On 25-Oct-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced VACCINATION SITE PAIN (Arm pain (injection arm)). On an unknown date, the patient experienced FATIGUE (extremely tired). On 27-Oct-2023, VACCINATION SITE PAIN (Arm pain (injection arm)) had resolved. At the time of the report, FATIGUE (extremely tired) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) was unknown.       Patient had arm pain (injection arm) and was extremely tired. The patient did not experience any additional symptoms/events.  No medicines were given to patient. The patient had no medical history, concomitant disease or risk factor. Concomitant medications were not reported.  No treatment information was provided by the reporter.
Right after the vaccine taken, maybe starting from next day, I felt cramp, soreness, pain on both legs until now. Especially during night time. Always woke up by the uncomfortable soreness and pain.  I went to see the doctor, and she had no idea about this issue.
Pt was given PROQUAD and VARIVAX on same day. On 12/06/18 medical assistant called parent to notify them of mistake. Father states patient developed a cough, but no other symptoms noted on 12/06/18. On 12/12/18 father calls office to let us know but now has 2 bumps with liquid. Asked father to bring child in to see doctor. Doctor examined child and noted 2 sores that popped open. 1 ulcer on the right ankle, and another ulcer on the left thigh, each scabbed over, 6-8mm. Minimal surrounding erythema. There are grouped pustules on the right upper thigh. Child is breathing well and drinking, but not eating very much. Dr. also noted acute serous otitis media to the left ear. States it could be due to general varicella infection. Recommends patient support and time to heal and let it run its course. Also told patients father to give us a call if symptoms do not improve or worsen.
Severe chills and feeling "sick" started 10 hours after injection on 1-7-2021.  Went to bed and chills continued.  Took Tylenol x 1 dose in the middle of the night.   Temp the following morning, 1-8-2021, was 102.1.  Treated with Tylenol and rest through out the day.  Temp at the evening on 1-8-2021 was 101.4.  Chills on and off throughout the day.  Injection site sore but no redness.    Temp resolved on morning of 1-9-2021.  Injection site still sore.  Continuing to take Tylenol PRN
IT WAS ADDITIONAL DOSE FOR MODERNA, AFTER 10 MINUTES PT FELT DIZZY, BLOOD PRESSURE WAS 220/100, PT WENT TO ER, BUT AFTER 2 TO 3 HOURES PT WAS OK
This study case was received from the investigator in a trial on 04 April 2012. A 21-year-old female subject received the following vaccinations: On 09 November 2011: an injection of ACAM2000 (lot number not reported) and ANTHRAX 2 (manufacturer and lot number not reported) and on 11 October 2011: an injection of TYPHIM VI, sanofi pasteur, lot number not reported and an injection of ANTHRAX 1 (manufacturer and lot number not reported). The subject had no significant medical history. On 15 November 2011, the subject had a normal electrocardiogram (ECG). On 17 November 2011, the subject had a normal troponin I and on 21 November 2011, the subject had a normal echocardiogram. On 22 November 2011, the subject was diagnosed with other, chest pain. The outcome was not reported. Additional information will be requested from the investigator. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: None.
Excruciating pain in arm receiving vaccination from fingers up arm to collar bone and shoulder blade.
*Moderna COVID-19 Vaccine* Reporting syringe failure.  When pharmacist was administering vaccine to pt, upon injecting the vaccine the medication leaked out of syringe and onto pts arm.  Pt was revaccinated.  No adverse event noted.
pericarditis; This is a spontaneous report from a contactable consumer based on information received by Pfizer from the Regulatory Authority (manufacturer control number 2021SA276022). A 50-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 01Aug2021 (Batch/Lot number was not reported) as single dose (dose number unknown) for COVID-19 immunisation and dupilumab (DUPIXENT) subcutaneous from 02Apr2021 and ongoing at 300 mg (once in every two weeks) for dermatitis atopic. Relevant medical history included dermatitis atopic. The patient's concomitant medications were not reported. The patient experienced pericarditis (medically significant) on 08Aug2021 with outcome of recovering. The patient went to emergency room due to pericarditis. It was not reported if the patient received a corrective treatment for the event pericarditis. No action was taken with dupilumab in response to the event.  Reporter casualty: unassessable for pericarditis in case of dupilumab: not reported for pericarditis in case of tozinameran. Company causality: not reportable for pericarditis for both the suspect.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
administered on 10Jun2022, expiration date 04Jun2022; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 58-year-old female patient who received HBV (Engerix B) (batch number 239TF, expiry date 4th June 2022) for prophylaxis.   On 10th June 2022, the patient received the 2nd dose of Engerix B. On 10th June 2022, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 21-Jun-2022 Reporter's Comments: The reporter stated that a patient was administered a dose of Engerix-B on 10th June 2022, with an expiration date of 04th June 2022. This was the patient's second dose in the series. At the time of reporting, repeat dose had not been administered. The reporter consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter. The reporter need to know the vaccine safety and efficacy data for a Hepatitis B vaccine that administered after the expiration date. Additional Supportive Information: The patient received Engerix B expired vaccine, which led to expired vaccine used.
pt recv vax 15OCT96 2PM & approx 315PM pt had redness @ inj site & felt sleepy;pt advised to go to ER or MD right away in case of allergic rxn;pt nauseous by time arrived @ pvt MD;pt given DPH;
Fever 102 in < 24 hrs. Vomiting x3 slight cough.
Recurrence of Bell's Palsy I had Bell's Palsy 30 years ago on the right side of my face - it never completely restored so I was left with some paralysis in my right cheek and my forehead.  I never had another episode until three weeks after receiving the Moderna vaccine.
HE ALREADY HAD OCASSIONAL MIGRAINES. THIS ONE STARTED AFTER THE VACCINE, AND HAS NOW BEEN 12 WEEKS +/-  THREE HOSPITALIZATIONS PLUS EMERGENCY ROOM VISITS, LOSS OF VISION IN LEFT EYE. NO RELIEF. PAIN STILL BETWEEN 8-10. BEEN ON EVERY DRUG IMAGINABLE. MANY TESTS. THEY RECENTLY TOOK A BIOPSY OF ARTERY IN HEAD. COMPLETELY DISABLED. SLEEPS AROUND THE CLOCK.  I DO NOT HAVE HIS CARD, HE DOES, the date and times are approximate.I CAN PROVIDE FURTHER INFORMATION. he is incapacitated and asleep. I can give exact dates times ets and batch number once I am contacted and hes awake
Tested positive for COVID-19 infection; Tested positive for COVID-19 infection; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 26Feb2021 as a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 12Mar2021, two weeks after the first dose of vaccination, the patient had tested positive for COVID-19 infection. The outcome of the event was unknown. The patient was asking if the second dose of vaccination could be received as scheduled on 26Mar2021.  Follow-up attempts are completed; information about lot/batch number cannot be obtained.
I missed 2 days of work.  Please keep in mind that I suffer from both migraines and fibro.  So, these side effects had to be pretty bad for me to miss work. Every joint in shot arm throbbed Migrating headache Nausea Everything hurt-muscles & joints  Mild covid arm again, but weird location.  It was about 3.5 cm down (towards elbow) from injection site
Raised red skin at injection site measuring 2.75" x 1.57" and increasing slowly. Painful, warm to touch. No itching. Have drawn circle around to validate start of size. Skin sensitivity on arms, legs, back, buttocks (similar to mild sunburn sensation), still ongoing. Scalp sensitivity/tenderness for 24 hours (has stopped). Sinus headache/pain when coughing only or bending over. Swollen lymph nodes in left armpit area, still ongoing. Feelings of hot/cold but no fever ongoing. Dizziness started approx. 25 min. while moving head too quickly or standing too quickly and continued approx. until 36 hours. Treating with Tylenol, ice, vitamins.
Twenty minutes after injection, tongue and throat started tingling. Tingling grew in intensity quickly. The sensation can be compared to having Pop Rocks candy in the mouth. Face became flushed red and paramedics were called.  Faint redness on underside of arms. Sensation of heat felt in scalp and neck. Fainting occurred. Paramedics determined reactions were not life-threatening. Tongue and throat were not swollen. Tingling sensation slowly diminished over the next eight hours. About an hour after injection, diarrhea occurred.
PRESSURE IN HER EARS; LOUDER RINGING IN EARS; QUEASY WHEN STANDS UP TOO FAST; REALLY HURT WHEN VACCINE WAS ADMINISTERED; DIZZY; This spontaneous report received from a patient concerned a 63 year old female. The patient's weight was 178 pounds, and height was 66 inches. The patient's past medical history included: motion sickness, and concurrent conditions included: herpes, smoker, non alcohol user, and cholesterol, and other pre-existing medical conditions included: The patient had no drug abuse or illicit drug. The patient experienced drug allergy when treated with chlorphenamine maleate/phenylpropanolamine hydrochloride for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 212A21A, and expiry: 21-DEC-2021) dose was not reported, administered on 29-SEP-2021 for prophylactic vaccination. Concomitant medications included valaciclovir for herpes, and ergocalciferol. On 29-SEP-2021, the patient experienced dizzy. On 29-SEP-2021, the patient experienced really hurt when vaccine was administered. On an unspecified date, the patient experienced pressure in her ears, louder ringing in ears, and queasy when stands up too fast. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizzy, louder ringing in ears, pressure in her ears, and queasy when stands up too fast, and the outcome of really hurt when vaccine was administered was not reported. This report was non-serious.
Warm to touch; Slightly tender; Arm has swollen up; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm has swollen up), FEELING HOT (Warm to touch) and TENDERNESS (Slightly tender) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm has swollen up) and TENDERNESS (Slightly tender). On an unknown date, the patient experienced FEELING HOT (Warm to touch). At the time of the report, PERIPHERAL SWELLING (Arm has swollen up), FEELING HOT (Warm to touch) and TENDERNESS (Slightly tender) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment information was reported.
an unknown amount of patients was administered a dose which undergone a temperature excursion; poor quality vaccine administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (an unknown amount of patients was administered a dose which undergone a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (poor quality vaccine administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Sep-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (an unknown amount of patients was administered a dose which undergone a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (poor quality vaccine administered). On 26-Sep-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (an unknown amount of patients was administered a dose which undergone a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (poor quality vaccine administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The HCP reported that an unknown amount of patients were administered a dose which undergone a temperature excursion 10 vials were administered to the patients, mostly they had a lot of waste. 1 or 2 patients might have received the vaccine. No concomitant medications were reported. No treatment medications were reported.
Client c/o of a little throat tightness during the 15 minute observation. Client taken to exam room. Vitals taken  Bp127/73, HR, 58, o2 96%, RR 14. Client given benadryl 25mg and observed for 30 more minutes.  Client stated throat improved. Breath sounds clear, heart sounds s1s2.
Temporary blindness. After feeling lightheaded and dizzy, sight was temporarily lost for a minute or two
PATIENT DID NOT APPEAR TO BE ALLERGIC TO THE VACCINE; PATIENTS ARM APPEARED RED IN A CIRCULAR MOTION THAT MIMICKED THE SIZE OF THE INJECT SAFE BARRIER BANDAGE. WAITED WITH PATIENT FOR APPRX. 15 MINUTES. ITCHING SEEMED TO LESSEN. PATIENT DID NOT WANT OTC BENADRYL BUT USED BENADRYL CREAM. WAITED 10 MORE MINUTES - PATIENT SAID MUCH BETTER. FOLLOWED UP WITH PHONE CALL 3 HOURS LATER AND PATIENT SAID OK.
Pain from the injection site almost to elbow when I raised my arm very much, esp, raising my arm high to change or pull on and off shirts. I also had severe chills and a fever of 99.8 degrees my usual is 97.5 degrees. I'm still having pain in my upper left shoulder, when I change shirts and other activity.
Rash, Saw PCP, ordered course of Prednisone. Rash somewhat subsided but was visible. In July the rash began to spread. Saw Doctor Im from same office. Provided depo shot, another course of Prednisone and Triamcinolone 0.1% ointment. Also provided a referral to a dermatologist.  Saw Doctor at  Dermatology. Did a punch biopsy with a diagnosis of Granuloma Annulare. Provided additional prescription of Triamcinolone 0.1% ointment and suggested light therapy, which I did not take advantage of. Doctor said the rash should subside in one to two years.
Received pneumonia shot in (L) arm. Hurt on & off severely for several days then kept hurting off & on less severely until last week when it began to hurt even without movement much more severe - saw Orthopedist, did X-ray but could see nothing - advised her to see regular MD.